A Phase III Study Evaluating Continuation, Tapering, and Withdrawal of Certolizumab Pegol After One Year of Therapy in Patients With Early Rheumatoid Arthritis. - Weinblatt, Michael E.; Bingham, Clifton O.; Burmester, Gerd‐Rüdiger; Bykerk, Vivian P.; Furst, Daniel E.; Mariette, Xavier; van der Heijde, Désirée; van Vollenhoven, Ronald; VanLunen, Brenda; Ecoffet, Cécile; Cioffi, Christopher; Emery, Paul (Arthritis & Rheumatology, 2017)